Adrian B McDermott

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. doi request reprint CD8(+) T cells in preventing HIV infection and disease
    Adrian B McDermott
    Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA
    AIDS 26:1281-92. 2012
  2. ncbi request reprint HIV vaccine research and discovery in the nonhuman primates model: a unified theory in acquisition prevention and control of SIV infection
    Rebecca M Lynch
    Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892, USA
    Curr Opin HIV AIDS 8:288-94. 2013
  3. pmc Virus inhibition activity of effector memory CD8(+) T cells determines simian immunodeficiency virus load in vaccinated monkeys after vaccine breakthrough infection
    Takuya Yamamoto
    Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, USA
    J Virol 86:5877-84. 2012

Collaborators

Detail Information

Publications3

  1. doi request reprint CD8(+) T cells in preventing HIV infection and disease
    Adrian B McDermott
    Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA
    AIDS 26:1281-92. 2012
    ..In the context of previous clinical HIV/AIDS vaccine trials, we consider the challenges faced by therapeutic and vaccine strategies designed to elicit effective HIV-specific CD8 T cells...
  2. ncbi request reprint HIV vaccine research and discovery in the nonhuman primates model: a unified theory in acquisition prevention and control of SIV infection
    Rebecca M Lynch
    Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892, USA
    Curr Opin HIV AIDS 8:288-94. 2013
    ....
  3. pmc Virus inhibition activity of effector memory CD8(+) T cells determines simian immunodeficiency virus load in vaccinated monkeys after vaccine breakthrough infection
    Takuya Yamamoto
    Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, USA
    J Virol 86:5877-84. 2012
    ..The ability to elicit such virus-specific EM CD8(+) T cells might contribute substantially to an efficacious HIV/AIDS vaccine, even after breakthrough infection...